VDR genotype and response to etidronate therapy in late postmenopausal women

Osteoporosis International

Volumn 10, Issue 4, 1999, Pages 303-306

  Marc, J ^a   Prezelj, J ^a   Komel, R ^a   Kocijancic, A ^a  

^a NONE

Author keywords

Bisphosphonate; Bone mineral density; BsmI polymorphism; Genetic factors; RFLP; Vitamin D receptor

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CALCIUM GLUBIONATE; ETIDRONIC ACID; HYDROXYPROLINE; OSTEOCALCIN; VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BODY WEIGHT; CALCIUM INTAKE; CLINICAL ARTICLE; DIET SUPPLEMENTATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYDROXYPROLINE URINE LEVEL; MENOPAUSE; OSSIFICATION; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL;

AGED; BIOLOGICAL MARKERS; BONE DENSITY; CALCIUM; ETIDRONIC ACID; FEMALE; GENOTYPE; HUMANS; HYDROXYPROLINE; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CALCITRIOL;

EID: 0032828750     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980050231     Document Type: Article

References (21)

1. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D. Guidelines for diagnosis and management of osteoporosis. Osteoporos Int 1997;7:390-406.
2. Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990;323:73-9.
3. Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The alendronate phase II osteoporosis treatment study group. N Engl J Med 1995;333:1437-43.
4. Miller PD, Watts NB, Licata AA, Harris ST, Genant HK, Wasnich RD, et al. Cyclical etidronate in the treatment of osteoporosis: efficacy and safety after seven years of treatment. Am J Med 1997;103:468-76.
5. Graafmans WC, Lips P, Ooms ME, van Leeuwen JPTM, Pols HAP, Uitterlinden AG. The effect of vitamin D supplementation on bone mineral density of the femoral neck is associated with vitamin D receptor genotype. J Bone Miner Res 1997;12:1241-5.
6. Ferrari S, Rizzoli R, Chevalley T, Slosman D, Eisman JA, Bonjour J-P. Vitamin D receptor gene polymorphism and the rate of change of lumbar spine bone mineral density in elderly men and women. Lancet 1995;345:423-4.
7. Miller SA, Dyches DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215-9.
8. Vandevyver C, Wylin T, Cassiman JC, Raus J, Geusens P. Influence of the vitamin D receptor gene alleles on bone mineral density in postmenopausal and osteoporotic women. J Bone Miner Res 1997;12:241-7.
9. Eisman JA. Vitamin D receptor gene variants: implications for therapy. Curr Opin Genet Dev 1996;6:361-5.
10. Keen RW, Kelly PJ. Genetic factors in osteoporosis: what are the implications for prevention and treatment. Drugs Aging 1997;11:333-7.
11. Krall EA, Parry P, Lichter JB, Dawson-Hughes B. Vitamin D receptor alleles and rate of bone loss: influence of years since menopause and calcium intake. J Bone Miner Res 1995;10:978-84.
12. Howard G, Nguyen TV, Morrison NA, et al. Genetic influence on bone mineral density: physiological correlates of vitamin D receptor gene alleles in premenopausal women. J Clin Endocrinol Metab 1995;80:2800-5.
13. Dawson-Hughes B, Harris SS, Finneran S. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 1995;80:3657-61.
14. Kiel DP, Myers RH, Cupples A, et al. The BsmI restriction length polymorphism (bb) influences the effect of calcium intake on bone mineral density. J Bone Miner Res 1997;12:1049-57.
15. Ferrari SL, Rizzoli R, Slosman DO, Bonjour JP. Do dietary calcium and age explain the controversy surrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms? J Bone Miner Res 1998;13:363-70.
16. Eisman JA. Vitamin D polymorphisms and calcium homeostasis: a new concept of normal gene variants and physiologic variation. Nutr Rev 1998;56:S22-9.
17. Ferrari G, Bonjour JP, Rizzoli R. The vitamin D receptor gene and calcium metabolism. Trends in Endocrinology and Metabolism 1998;9:259-65.
18. Matsuyama T, Ishii S, Tokita A, et al. VDR gene polymorphisms and vitamin D analog treatment in Japanese. Lancet 1995;345:1238-9.
19. Nakamura T. The importance of genetic and nutritional factors in response to vitamin D and its analogs in osteoporotic patients. Calcif Tissue Int 1997;60:119-23.
20. Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 1993;18:460-4.
21. Hosking DJ, Ross PD, Thompson DE, et al. Evidence that increased calcium intake does not prevent early postmenopausal bone loss. Clin Ther 1998;20:933-44.